Clinical Trial

Pediatric and Ambulatory Research in Infectious Diseases

Study acronym: PARI
Recruiting
View on ClinicalTrials.gov →
Summary
Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-07-10; most recent amendment 2024-02-07.
Trial Details
NCT Number NCT04471493
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: AFPA (Association Française de Pédiatrie Ambulatoire), GlaxoSmithKline, Sanofi, Pfizer, Merck Sharp & Dohme LLC
Conditions Otitis, Bronchiolitis, Influenza, Pharyngitis, Varicella, Pneumonia, Gastroenteritis
Enrollment 400,000 participants
Start Date 2017-06-26
Primary Completion 2030-06-27 (estimated)
Study Completion 2030-08-02 (estimated)
Updated on ClinicalTrials.gov 2024-02-08